Status: Recruiting
Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)
Prospective study to evaluate the relevance of CALR allele burden monitoring as a molecular marker of disease progression.
Participants needed: 260
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, AngersUpdated: Mar 6, 2026Locations: 10
Eligibility criteria
adults (age ≥18 years), [+5]
patient with another active hematological disease or cancer at the time of diagn... [+1]